121 related articles for article (PubMed ID: 21256179)
1. Acetyl-l-Carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects.
Martinotti G; Andreoli S; Reina D; Di Nicola M; Ortolani I; Tedeschi D; Fanella F; Pozzi G; Iannoni E; D'Iddio S; Prof LJ
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):953-8. PubMed ID: 21256179
[TBL] [Abstract][Full Text] [Related]
2. Acetyl-L-carnitine for alcohol craving and relapse prevention in anhedonic alcoholics: a randomized, double-blind, placebo-controlled pilot trial.
Martinotti G; Reina D; Di Nicola M; Andreoli S; Tedeschi D; Ortolani I; Pozzi G; Iannoni E; D'Iddio S; Janiri L
Alcohol Alcohol; 2010; 45(5):449-55. PubMed ID: 20595193
[TBL] [Abstract][Full Text] [Related]
3. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
Malaguarnera M; Gargante MP; Cristaldi E; Colonna V; Messano M; Koverech A; Neri S; Vacante M; Cammalleri L; Motta M
Arch Gerontol Geriatr; 2008; 46(2):181-90. PubMed ID: 17658628
[TBL] [Abstract][Full Text] [Related]
4. Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome.
Janiri L; Martinotti G; Tonioni F; Ghelardini C; Nicolai R; Galeotti N; Mosconi L; Calvani M; Bartolini A; Iannoni E
Clin Neuropharmacol; 2009; 32(1):35-40. PubMed ID: 18978503
[TBL] [Abstract][Full Text] [Related]
5. Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.
Malaguarnera M; Bella R; Vacante M; Giordano M; Malaguarnera G; Gargante MP; Motta M; Mistretta A; Rampello L; Pennisi G
Scand J Gastroenterol; 2011 Jun; 46(6):750-9. PubMed ID: 21443422
[TBL] [Abstract][Full Text] [Related]
6. L-Acetylcarnitine in dysthymic disorder in elderly patients: a double-blind, multicenter, controlled randomized study vs. fluoxetine.
Bersani G; Meco G; Denaro A; Liberati D; Colletti C; Nicolai R; Bersani FS; Koverech A
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1219-25. PubMed ID: 23428336
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
Tomassini V; Pozzilli C; Onesti E; Pasqualetti P; Marinelli F; Pisani A; Fieschi C
J Neurol Sci; 2004 Mar; 218(1-2):103-8. PubMed ID: 14759641
[TBL] [Abstract][Full Text] [Related]
8. Acetyl-L-carnitine.
Altern Med Rev; 1999 Dec; 4(6):438-41. PubMed ID: 10608918
[TBL] [Abstract][Full Text] [Related]
9. Effect of acetyl-L-carnitine in the treatment of painful peripheral neuropathies in HIV+ patients.
Scarpini E; Sacilotto G; Baron P; Cusini M; Scarlato G
J Peripher Nerv Syst; 1997; 2(3):250-2. PubMed ID: 10975731
[TBL] [Abstract][Full Text] [Related]
10. L-acetyl-carnitine in Huntington's disease: double-blind placebo controlled crossover study of drug effects on movement disorder and dementia.
Goety CG; Tanner CM; Cohen JA; Thelen JA; Carroll VS; Klawans HL; Fariello RG
Mov Disord; 1990; 5(3):263-5. PubMed ID: 2143808
[No Abstract] [Full Text] [Related]
11. Role of acetyl-L-carnitine in the treatment of cognitive deficit in chronic alcoholism.
Tempesta E; Troncon R; Janiri L; Colusso L; Riscica P; Saraceni G; Gesmundo E; Calvani M; Benedetti N; Pola P
Int J Clin Pharmacol Res; 1990; 10(1-2):101-7. PubMed ID: 2201652
[TBL] [Abstract][Full Text] [Related]
12. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS.
Beghi E; Pupillo E; Bonito V; Buzzi P; Caponnetto C; Chiò A; Corbo M; Giannini F; Inghilleri M; Bella VL; Logroscino G; Lorusso L; Lunetta C; Mazzini L; Messina P; Mora G; Perini M; Quadrelli ML; Silani V; Simone IL; Tremolizzo L;
Amyotroph Lateral Scler Frontotemporal Degener; 2013 Sep; 14(5-6):397-405. PubMed ID: 23421600
[TBL] [Abstract][Full Text] [Related]
13. L-acetylcarnitine in depressed elderly subjects. A cross-over study vs placebo.
Tempesta E; Casella L; Pirrongelli C; Janiri L; Calvani M; Ancona L
Drugs Exp Clin Res; 1987; 13(7):417-23. PubMed ID: 3308388
[TBL] [Abstract][Full Text] [Related]
14. Effect of acetyl-L-carnitine on geriatric patients suffering from dysthymic disorders.
Bella R; Biondi R; Raffaele R; Pennisi G
Int J Clin Pharmacol Res; 1990; 10(6):355-60. PubMed ID: 2099360
[TBL] [Abstract][Full Text] [Related]
15. L-acetylcarnitine as a new therapeutic approach for peripheral neuropathies with pain.
Onofrj M; Fulgente T; Melchionda D; Marchionni A; Tomasello F; Salpietro FM; Alafaci C; De Sanctis E; Pennisi G; Bella R
Int J Clin Pharmacol Res; 1995; 15(1):9-15. PubMed ID: 7490173
[TBL] [Abstract][Full Text] [Related]
16. Acetyl-l-carnitine versus placebo for migraine prophylaxis: A randomized, triple-blind, crossover study.
Hagen K; Brenner E; Linde M; Gravdahl GB; Tronvik EA; Engstrøm M; Sonnewald U; Helde G; Stovner LJ; Sand T
Cephalalgia; 2015 Oct; 35(11):987-95. PubMed ID: 25601916
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, placebo-controlled study of L-acetylcarnitine for the treatment of hyperactive behavior in fragile X syndrome.
Torrioli MG; Vernacotola S; Mariotti P; Bianchi E; Calvani M; De Gaetano A; Chiurazzi P; Neri G
Am J Med Genet; 1999 Dec; 87(4):366-8. PubMed ID: 10588848
[No Abstract] [Full Text] [Related]
18. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
Herrmann WM; Dietrich B; Hiersemenzel R
Int J Clin Pharmacol Res; 1990; 10(1-2):81-4. PubMed ID: 2201660
[TBL] [Abstract][Full Text] [Related]
19. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain.
Bonavita E
Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):511-6. PubMed ID: 3781687
[TBL] [Abstract][Full Text] [Related]
20. Patient characteristics and treatment implications of marijuana abuse among bipolar alcoholics: results from a double blind, placebo-controlled study.
Salloum IM; Cornelius JR; Douaihy A; Kirisci L; Daley DC; Kelly TM
Addict Behav; 2005 Oct; 30(9):1702-8. PubMed ID: 16098680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
